About hVIVO
hVIVO is a publicly listed company based in London (United Kingdom) founded in 1998. Provider of cell based assays, field trial, and molecular services for biopharma sector. The company has 133 employees. hVIVO has completed 2 acquisitions, including Activiomics and Cryo Store. hVIVO offers products and services including Human Challenge Trials, Laboratory Services, and Clinical Trial Recruitment. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its legal entity is HVIVO SERVICES LIMITED.
Company details
hVIVO was founded in 1998 and is headquartered in London, United Kingdom. Operations focus on the biopharma sector, where cell-based assays, field trials, and molecular services are delivered to support research and development. These offerings assist in drug discovery and validation processes, with activities centered in the UK and extending to international clients through the hvivo.com domain.
- Annual Revenue$62.98 M (USD)-25.43as on Dec 31, 2025
- Net Profit-$8.07 M (USD)-156.26as on Dec 31, 2025
- EBITDA-$1.98 M (USD)-111.34as on Dec 31, 2025
- Latest Funding Round$8.4M (USD), Post-IPO
Jan 2024
- InvestorsIP Group
& 1 more
- Employee Count133
- Investments & AcquisitionsActiviomics
& 1 more
Products & Services of hVIVO
hVIVO offers a comprehensive portfolio of products and services, including Human Challenge Trials, Laboratory Services, and Clinical Trial Recruitment.
Controlled testing of vaccines for infectious diseases in volunteers.
Analysis and support for clinical trials on respiratory illnesses.
Recruitment and management of volunteers for medical research studies.
Funding Insights of hVIVO
- Total Rounds 3
- Last Round Post-IPO — $8.4M
- First Round $30.95M
(Nov 2015)
- Investors Count 2
All 3 funding rounds of hVIVO with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2024 | $8.4M | Post-IPO | – | – | – |
| Aug 2018 | Post-IPO | – | – | ||
| Nov 2015 | $30.95M | Post-IPO | – | – |
2 investors in total: 2 institutional.
Investors in hVIVO
hVIVO has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include IP Group and Woodford Investment Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital and advisory services are offered across multiple sectors. | 2001 | ipgroupplc.com | London, United Kingdom | |
Diversified investment portfolios are managed for clients by the firm. | 2014 | woodfordfunds.com | Swindon, United Kingdom |
Investor details for hVIVO
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of hVIVO
16 people are tracked at hVIVO (6 in leadership, 10 in team); the tracked headcount is 133.
| Name | Role | Group |
|---|---|---|
Stephen Pinkerton | Chief Financial Officer | Leadership |
Ian O'Connell | VP Corporate Development | Leadership |
Yamin 'Mo' Khan | Chief Executive Officer | Leadership |
Andrew Frans | Head of HR | Leadership |
Rich Niemi | Senior Director Business Development | Leadership |
Carol Dalton | VP, Investor Relations & Public Relations | Leadership |
Aninder Singh Dhamrat | Financial Accountant | Team |
Charlotte Davies | Senior Finance Manager | Team |
Jack Kelly | Corporate Finance | Team |
Beishan S. | Financial Controller | Team |
Sam Sugden | Group Financial Controller | Team |
Jodie M. | Human Resources Generalist | Team |
Ellie Martin | Recruitment Officer | Team |
Oliver Cant | Senior Fp&a Manager | Team |
Vasyl Pariy | Finance Systems Administrator | Team |
Joe Coultish | Finance Analyst | Team |
Complete people profiles for hVIVO
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of hVIVO
hVIVO is a publicly listed company on the LSE with ticker symbol HVO in UK, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date05 Jun 2020
- Listed onOTCMKTS: OPORF
- Listed entityhVIVO plc
- Exchange sectorCommercial services
- ISINGB00B9275X97
- Share price5.80 GBX (-1.63% on the day) · 2026-10-14
- Market capitalisation40,615,663.00 GBX
- EPS (diluted, trailing year)-0.02 GBX
- Dividend yield3.39%
- Volume (last session)5,250
Financials of hVIVO
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 46.8M GBP | -6.0M GBP | -1.5M GBP |
| 2024 | 62.7M GBP | 10.7M GBP | 12.9M GBP |
| 2023 | 56.0M GBP | 16.1M GBP | 10.2M GBP |
| 2022 | 48.5M GBP | -776,000 GBP | 6.8M GBP |
| 2021 | 36.9M GBP | -74,000 GBP | 720,000 GBP |
Detailed financial statements for hVIVO
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by hVIVO
hVIVO has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Activiomics and Cryo Store.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Tools for biostorage | cryostore.com | Joure, Netherlands | 1999 | Feb 2025 | $4.09M | |
Phosphoproteomic solutions are offered for biomarker discovery and drug development. | activiomics.com | London, United Kingdom | 2009 | Mar 2014 | $6.69M |
Complete acquisition details for hVIVO
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of hVIVO
7 dated milestones of hVIVO across 27 years, from founding to its latest funding, stage changes and deals.
- Founded hVIVO is founded.
- Acquisition Acquires Activiomics.
- Funding First funding round of $30.9M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $8.4M.
- Acquisition Acquires Cryostore.
- Acquisition Acquires Cryo Store.
Web traffic of hVIVO
The website of hVIVO (hvivo.com) receives about 6.7K visits a month and ranks #2,797,683 among all websites worldwide, #3,761 in Biotechnology and Pharmaceuticals.
- Monthly visits6.7K
▼ 19% vs previous month
- Unique visitors3.6K
per month
- Global rank#2,797,683
among all websites
- Category rank#3,761
Health · Biotechnology and Pharmaceuticals
- Bounce rate64%
- Pages per visit1.4
- Average visit16 sec
- DevicesDesktop 29% · Mobile 71%
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hvivo
Complete news archive for hVIVO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about hVIVO
hVIVO was founded in 1998 and raised its 1st funding round 17 years after it was founded.
hVIVO is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
hVIVO has 133 employees.
Annual revenue of hVIVO is $62.98M as on Dec 31, 2025.
hVIVO was founded in 1998 and is headquartered in London, United Kingdom. Operations focus on the biopharma sector, where cell-based assays, field trials, and molecular services are delivered to support research and development. These offerings assist in drug discovery and validation processes, with activities centered in the UK and extending to international clients through the hvivo.com domain.
hVIVO offers Human Challenge Trials, Laboratory Services, and Clinical Trial Recruitment.
Yes, hVIVO is publicly traded on LSE under the ticker symbol HVO.
hVIVO has made 2 acquisitions, including Activiomics, and Cryo Store.
hVIVO has 2 investors. Key investors include IP Group, and Woodford Investment Management.
hVIVO operates through Hvivo Services Limited.